<DOC>
	<DOCNO>NCT00604266</DOCNO>
	<brief_summary>To evaluate feasibility performance coregistered 18F-FDG-PET/MRI staging potentially respectable hilar cholangiocarcinoma .</brief_summary>
	<brief_title>Coregistration 18F-FDG-PET MRI Staging Potentially Resectable Hilar Cholangiocarcinoma : Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Cholangiocarcinoma</mesh_term>
	<mesh_term>Klatskin Tumor</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>Hilar cholangiocarcinoma assess conventional imaging modality ( triphasic CT scan liver ) think potentially resectable . Biliary drain insert . Contraindication MRI . Pregnant breastfeeding . Uncontrolled diabetes ( 9.7 mmol/L ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Potentially resectable hilar cholangiocarcinoma per initial imaging study .</keyword>
	<keyword>Able undergo PET/CT MRI Gadolinium</keyword>
</DOC>